All News

A cancer survivor describes how happy she was to return to the public swimming pool after getting her COVID-19 vaccine.

Katie Brown, senior vice president of survivorship and support for LUNGevity Foundation, wrote about a program for patients to gain knowledge from survivors.

One nurse describes how her colleague incorporates compassion into every aspect of her role as an oncology nurse.

A stage 3 bowel cancer survivor who recently found out she was in remission writes a poem about maintaining her identity despite cancer.

In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.

A modeling study demonstrated that breast cancer mortality may increase by 0.52% by 2030, but effects of delays during the COVID-19 pandemic may be mitigated by making up screenings sooner than later.

When patients with mantle cell lymphoma are discussing the use of a BTK inhibitor, they must consider what their insurance will cover, as well as current health complications and potential side effects.

The kinase inhibitor Rezurock was well tolerated in patients with chronic graft-versus-host disease who received up to five lines of prior systemic therapy.

A woman describes a nurse that helped her mother during her cancer journey, a time that can be described as an ‘unwanted and unwelcomed horror in their life.’

A woman shares the story of her journey with multiple cancer types, including the same one that her mother died from.

From Ashley Monroe’s blood cancer diagnosis to a CrossFit athlete’s inspiring cancer journey, here’s what’s happening in the cancer landscape this week.

Having a pet to care for may motivate patients to exercise and be positive when undergoing cancer treatment.

Most research looked at the broad category of myeloid malignancies, not each individual disease.

Myeloproliferative neoplasms are rare in children. Here are some tips on navigating the uncertainty of a rare cancer diagnosis.

Patients and their caregivers can navigate a terminal cancer diagnosis while keeping dignity intact.

A woman in remission from her cancer ponders why the disease seemingly chooses to steal certain lives and spare others.

In this episode of the “CURE® Talks Cancer” podcast, a woman explains how she underwent surgery and chemotherapy for cancer just months before competing in American Ninja Warrior.

Several sunscreens packaged with aerosol were found to contain benzene, which has been associated with risk of leukemia.

“There’s an infinite amount of information out there, but there’s not an infinite amount of quality information,” said an MPN expert.

Gastrointestinal stromal tumors that are SDH deficient are less likely to respond to TKI treatment. A researcher discusses the exploration of a new drug that can work in this patient population.

Patients can now prioritize whether durable responses to treatment or avoiding certain side effects are more valuable to them.

A woman with metastatic cancer explains how she found a copay assistance program and specialty pharmacy to help manage the cost of pricey medications, though not without a few bumps in the road.

With summer in full swing, it’s time to host a get-together. Impress your guests with a fresh summer salsa and a salad with a twist. What about dessert? Don’t worry — this one is guilt-free.

Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials.

Patients with mantle cell lymphoma whose disease relapses within a year and a half of transplant tend to have worse outcomes and may want to consider new treatment regimens.

One expert talks the benefits of excising in surgical management, as well as what to expect after.

Newer cancer therapies easily cost upward of $100,000. Why so much? Who sets the prices and what can patients do if they can't afford them?

A survivor of pancreatic cancer looks back on the day he received his diagnosis, and shares advice for others in the same shoes.

Patients, clinicians and researchers should work together to find new therapies for rare cancers, one expert says.

A hard-charging executive felt lost after surviving cancer because she didn’t fit into her old life. But, she says, “cancer changed my life, so I changed my world.”